Skip to main content
Advertisement
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
ADVERTISEMENT
Percutaneous Revascularization
Interview
Percutaneous Revascularization for SFA/Popliteal Arterial Disease: When and Why
09/05/2008
Michael R. Jaff , MD, DO;
Gary M. Ansel , MD, FACC;
Frank J. Criado , MD;
Sandeep Khosla , MD, FACC, FSCAI;
Nicolas W. Shammas , MD, MS, FACC, FSCAI, FACP, FSVM;
David E. Allie , MD;
In our experience, 40-50% of CLI patients will have SFA/popliteal involved and 30-40% in LACI trial.
In our experience, 40-50% of CLI patients will have SFA/popliteal involved and 30-40% in LACI trial.
In our experience, 40-50% of CLI...
09/05/2008
Vascular Disease Management
Featured Webinar
Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications
Advertisement
Advertisement
Advertisement
Advertisement
Upcoming Events
March 23 – March 24
April 27 – April 28
November 30 – December 2
November 27 – November 29
December 12 – December 13
May 13 – May 14
February 2 – February 5
February 27 – March 1
March 17 – March 19
See Full Calendar
Advertisement
Advertisement
Advertisement